When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

about

Prognostic impact of the expression of NCR1 and NCR3 NK cell receptors and PD-L1 on advanced non-small cell lung cancer.

P2860

Q37616484-689425A4-ADBD-4F66-BAB9-B2FBAF20FFD0

P2860

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

Item

http://www.wikidata.org/entity/Q42726223

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@en

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@nl

type

Item

label

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@en

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@nl

prefLabel

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@en

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@nl

P1476

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

@en

P2093

Anne Caignard

http://www.w3.org/2001/XMLSchema#string

Marie-Françoise Avril

http://www.w3.org/2001/XMLSchema#string

Meriem Messaoudene

http://www.w3.org/2001/XMLSchema#string

P2860

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

Inhibition of Mutated, Activated BRAF in Metastatic Melanoma

Mutations of the BRAF gene in human cancer

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.

Host immunity contributes to the anti-melanoma activity of BRAF inhibitors.

Targeted therapies to improve tumor immunotherapy.

Mutations of the von Hippel-Lindau gene confer increased susceptibility to natural killer cells of clear-cell renal cell carcinoma.

NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies.

Mature cytotoxic CD56(bright)/CD16(+) natural killer cells can infiltrate lymph nodes adjacent to metastatic melanoma.

P304

e28048

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/ONCI.28048

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meriem Messaoudene

Anne Caignard

P577

2014-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

267735984

http://www.w3.org/2001/XMLSchema#string

P698

25340005

http://www.w3.org/2001/XMLSchema#string

P932

4203499

http://www.w3.org/2001/XMLSchema#string

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

about

P2860

P2860

When unity makes strength: Combinatorial NK cell-based immunotherapies against melanoma

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P5875

P698

P932